Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00255281 | Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation | PHASE2 | COMPLETED | 160 | — | — | Sep 1, 2005 | May 1, 2006 | Dec 6, 2007 | 32 | Denmark, Finland +6 |
| Name | Type | Description |
|---|---|---|
| AZD7009, no generic name available | DRUG | - |
Inclusion Criteria: * Clinical indication for cardioversion of Atrial Fibrillation. Effective oral anticoagulation according to local routines or a TEE without any finding of intracardial thrombus or signs of thrombogenecity Exclusion Criteria: * Clinically significant sinus and/or AV node dysfun...